We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mast Cell Activation Test Diagnoses Allergic Diseases

By LabMedica International staff writers
Posted on 16 May 2018
Print article
Image: Mast cells obtained from the human bone marrow; May-Grünwald/Giemsa stain of a resting human mast cell and a mast cell following activation-induced degranulation. Note the loss of granule staining (Photo courtesy of University Hospital of Bonn).
Image: Mast cells obtained from the human bone marrow; May-Grünwald/Giemsa stain of a resting human mast cell and a mast cell following activation-induced degranulation. Note the loss of granule staining (Photo courtesy of University Hospital of Bonn).
Peanut allergies are among the most common food allergies in children. Currently, doctors diagnose peanut allergy using a skin-prick test or immunoglobulin E (IgE) test, but this may result in over-diagnosis or false-positives and it cannot differentiate between sensitivity and true food allergy.

When skin-prick and IgE test results are unclear, allergists rely on an oral food challenge (OFC), which consists of feeding peanut in incrementally larger doses to a patient in a highly controlled setting in hospital to confirm allergy to the food. While the test is the gold standard for diagnosing food allergies, there is risk of causing severe allergic reactions.

Scientists at the University of Manchester (Manchester, UK) and their colleagues have developed a new laboratory test to diagnose peanut allergy. The team used blood samples from 174 children participating in allergy testing, 73 peanut allergic and 101 peanut-tolerant, the scientists added peanut protein to mast cells to screen for IgE-mediated activation. Levels of total IgE, peanut-specific IgE, and IgE to the recombinant allergen components were measured by using ImmunoCAP. Skin prick tests (SPTs) were undertaken according to national guidelines by using lancets and commercial peanut extract, with 1% histamine as a positive control. Images of mast cell activation were collected on an Olympus BX51 upright microscope.

The scientists found that human blood-derived mast cells (MCs) sensitized with sera from patients with peanut, grass pollen, and Hymenoptera (wasp venom) allergy demonstrated allergen-specific and dose-dependent degranulation, as determined based on both expression of surface activation markers (CD63 and CD107a) and functional assays (prostaglandin D2 and β-hexosaminidase release). In this cohort of peanut-sensitized subjects, the mast cell activation test (MAT) was found to have superior discrimination performance compared with other testing modalities, including component-resolved diagnostics and basophil activation tests. They identified five clusters or patterns of reactivity in the resulting dose-response curves, which at preliminary analysis corresponded to the reaction phenotypes seen at challenge.

The authors concluded that the MAT is a robust tool that can confer superior diagnostic performance compared with existing allergy diagnostics and might be useful to explore differences in effector cell function between basophils and MCs during allergic reactions. The study was published on March 5, 2018, in The Journal of Allergy and Clinical Immunology.

Related Links:
University of Manchester

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.